Xenon Pharmaceuticals Inc (STU:XP0)
€ 38.4 -0.2 (-0.52%) Market Cap: 2.90 Bil Enterprise Value: 2.27 Bil PE Ratio: 0 PB Ratio: 3.56 GF Score: 47/100

Q2 2023 Xenon Pharmaceuticals Inc Earnings Call Transcript

Aug 09, 2023 / 08:30PM GMT
Release Date Price: €32.4
Operator

Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the Xenon Pharmaceuticals Report Second Quarter 2023 Results Conference Call. (Operator Instructions) After the speakers' presentation, there will be a question-and-answer session.

I will now turn the call over to Sherry Aulin, Chief Financial Officer.

Sherry Aulin
Xenon Pharmaceuticals Inc. - CFO

Good afternoon. Thank you for joining us on our call and webcast to discuss Xenon's second quarter 2023 financial and operating results. Joining me are Ian Mortimer, Xenon's President and Chief Executive Officer; Dr. Chris Kenney, Xenon's Chief Medical Officer; and Dr. Chris Von Seggern, Xenon's Chief Commercial Officer. Ian will open today's call with a summary of our proprietary pipeline programs and Chris Kenney will provide an overview of our ongoing XEN1101 clinical program. I will summarize our financial results, progress within our partnered programs and our anticipated company milestone events. Chris Von Seggern will be available during our Q&A session to address

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot